HANSOH PHARMA'S NEW LICENSE-IN BREAKTHROUGH! INNOVATIVE ANTIFUNGAL DRUG BREXAFEMME (IBREXAFUNGERP) APPROVED BY FDA
On June 2, Synexis, a partner of Jiangsu Hansoh Pharmaceutical Group Co., Ltd. ("Hansoh Pharma" or the "Company"), announced that the innovative antif...
2021.06.04